Editorial: Molecular biomarkers of cardiometabolic disease

Frontiers Media SA

Editorial: Molecular biomarkers of cardiometabolic disease - volume II

Preuzmite dokument 2026 Mirjana Macvanin , Aleksandra Klisic

Journal of Medicine and Palliative Care

Associations of hsCRP, anthropometric, and biochemical parameters with cardiovascular risk in menopause status: a cross-sectional study

Aims: Cardiovascular disease (CVD) risk increases significantly after menopause, partly due to hormonal changes leading to abdominal obesity, dyslipidemia, and low-grade inflammation. High-sensitivity C-reactive protein (hsCRP) is a well-established biomarker of subclinical inflammation, yet its associations with anthropometric and biochemical parameters in menopausal women remain incompletely defined. To evaluate cardiovascular risk across hsCRP-based subgroups in menopausal women and identify...

Preuzmite dokument 2025 Filiz Mercantepe , Aleksandra Klisic , Alev Lazoğlu Özkaya , Elma Kalac

MDPI AG

Transcriptomic, Redox Status and Adipocytokine Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Impact of Coexisting Type 2 Diabetes

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) commonly coexists with type 2 diabetes (T2D), but their independent contributions to redox imbalance, inflammation and immune signaling remain uncertain. Objectives: This study aimed to evaluate whether the presence of MASLD alone, and the presence of T2D within MASLD, are independently associated with high-risk profiles of oxidative/antioxidant markers, peripheral blood mononuclear cell (PBMC) gene expression and adipocytokines....

Preuzmite dokument 2025 Sanja Erceg , Miron Sopić , Boško Misita , Miloš Mitrović , Jelena Kotur-Stevuljevic , Aleksandra Klisic , Milica Mamić , Ana Ninic , Jelena Munjas , Omar Ben Mariem , ... Pogledajte sve

Informa UK Limited

Endocan in nonalcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis

Preuzmite dokument 2025 Filiz Mercantepe , Alireza Yaghoobi , Sai Gautham Kanagala , Zahra Shokri Varniab , Amirmohammad Khalaji , Amir Hossein Behnoush , Elaheh Karimi , Aleksandra Klisic

MDPI AG

SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era

Cardiovascular (CV) disease, chronic kidney disease, obesity, and diabetes mellitus have reached epidemic proportions over the past few decades. Accumulating evidence highlights the strong interconnection between these conditions, leading to the definition of a broader disease entity known as cardio-renal-metabolic (CRM) syndrome. This newly recognized clinical entity presents important challenges in identifying the optimal treatment strategy within a holistic, patient-centered framework. In line...

Preuzmite dokument 2025 Paschalis Karakasis , Efstratios Karagiannidis , Antonios P. Antoniadis , Nikolaos Fragakis , Athina Nasoufidou , Aleksandra Klisic , Konstantinos Grigoriou , Djordje S. Popovic , Panagiotis Stachteas , Dimitrios Patoulias , ... Pogledajte sve